Pediatrics
Conference Coverage
Clinic eases pediatric-adult transition in sickle cell disease
CONCORD, N.C. – Transitional programs could help teenage patients continue self-care and avoid risk behaviors.
Conference Coverage
Emicizumab reduces bleeds in kids with hemophilia A and inhibitors
ATLANTA—Updated results from the HAVEN 2 trial have shown that emicizumab prophylaxis can reduce bleeds in children with hemophilia A and factor...
From the Journals
Parents taking photos of kids’ lesions for telederm diagnosis looks promising
Concordance of teledermatology and in-person diagnoses was high.
News
System helps predict RFS, OS in BCP-ALL
Researchers say they have developed a more accurate risk scoring system for children with B-cell precursor acute lymphoblastic leukemia (BCP-ALL)...
News
CCSs have increased risk of hypertension
A study of childhood cancer survivors (CCSs) suggests these individuals have an increased risk of developing hypertension as adults. The CCSs...
News
Nilotinib approved to treat kids with CML in EU
The European Commission has approved nilotinib (Tasigna®) for the treatment of pediatric patients. The drug is now approved to treat children age...
News
CD22-CAR therapy shows activity in rel/ref B-ALL
Researchers say they have reported the first results demonstrating clinical activity of a CD22-directed chimeric antigen receptor (CAR) T-cell...
From the Journals
In children with ALL, physical and emotional effects persist
Evaluations of quality of life and family functioning as early as 2 months after diagnosis identified those at highest risk of continued...
News
Results support using MTD of HU in kids with SCA
Dosing of hydroxyurea (HU) in young patients with sickle cell anemia (SCA) should target a fetal hemoglobin (HbF) level above 20%, according to...
News
CHMP recommends approval of romiplostim in kids
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended expanding the approved indication for...
News
Dasatinib approved to treat kids with CML
The US Food and Drug Administration (FDA) has expanded the approved use of dasatinib (Sprycel®). The drug is now approved to treat children with...